Hüls C, Müllner S
Hoechst AG, Corporate Research and Technology, Frankfurt/Main, Germany.
Arzneimittelforschung. 1997 Feb;47(2):233-6.
At the end of September '96, the Club de Bruxelles held a conference ("The Future of Biotechnologies in Europe") to discuss the present development and the future of biotechnology in Europe. The meeting was intended to serve as a forum for the preparation of the 5th EU framework ("Inventing Tomorrow"), which is currently being set up under the leadership of Edith Cresson. The aim of the conference was to underline the necessity of concentrating and reorganizing research in the field of biotechnology, thus focusing future research activities in order to secure Europe's competitiveness in the world market. The conference was attended by 350 participants from all over Europe, representing academia, industry, environmental organizations and consumer groups. Lectures were held by representatives from academic and industrial research and a variety of work groups of the European Parliament. The speakers and participants were mainly chosen to promote the dialogue between the different groups. The objectives were the creation of a common basis for further debate in the field of biotechnology and the preparation of future consent. Once again, this conference emphasized the need to inform the public as a prerequisite for the acceptance of biotechnology and its various aspects.
1996年9月底，布鲁塞尔俱乐部召开了一次会议（“欧洲生物技术的未来”），以讨论欧洲生物技术的当前发展及未来。此次会议旨在作为筹备第五届欧盟框架计划（“创造明天”）的一个论坛，该计划目前正在伊迪丝·克勒松的领导下制定。会议的目的是强调集中和重组生物技术领域研究的必要性，从而确定未来的研究活动重点，以确保欧洲在世界市场上的竞争力。来自欧洲各地的350名与会者参加了会议，他们代表了学术界、产业界、环境组织和消费者团体。学术和产业研究的代表以及欧洲议会的多个工作小组进行了讲座。演讲者和与会者的选择主要是为了促进不同团体之间的对话。目标是为生物技术领域的进一步辩论建立共同基础，并为未来达成共识做准备。此次会议再次强调，作为接受生物技术及其各个方面的前提条件，有必要向公众进行宣传。
